Tesamorelin
Stabilised GHRH Analogue
Trans-3-hexenoic acid-modified GHRH analogue with enhanced stability. Studied for visceral adiposity reduction, IGF-1 elevation, and metabolic improvement in research models.
Format
5mg / vial
Purity
>99.2%
Category
Performance
Storage
2–8 °C
Research Price
€89
5mg / vial
RESEARCH USE ONLY
This compound is sold exclusively for in-vitro laboratory research. It is not intended for human consumption, therapeutic use, or self-administration. You must be 18+ and a qualified researcher to purchase.
Complete Your Research with the Pen Kit
Precise, painless, repeatable. The clinical-grade injection pen with 32G ultra-fine needles, bacteriostatic water, and your choice of peptide — ready to use out of the box.
€189
View details →IMPORTANT RESEARCH DISCLAIMER
This compound is for in-vitro research and laboratory use only. It has not been evaluated or approved by any regulatory authority for human therapeutic use. It must not be used as a food, drug, or cosmetic. SYNTHEXA™ assumes no liability for misuse. Handle in accordance with Good Laboratory Practice.